Hou Qian, Zhang Biao, Liu Juanyao, Luo Yao, Shang Panfeng
Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China.
J Laparoendosc Adv Surg Tech A. 2023 Jul;33(7):672-677. doi: 10.1089/lap.2023.0078. Epub 2023 Apr 22.
The objective of this study was to compare the efficacy and safety of open adrenalectomy (OA) and laparoscopic adrenalectomy (LA) by summarizing the clinical features and treatment experience of giant adrenal tumors. The clinical data of 44 patients with adrenal tumors ≥10 cm admitted to the Second Hospital of Lanzhou University from January 2006 to August 2022 were retrospectively analyzed. The mean tumor diameter was 11.6 ± 1.8 cm. Regular follow-up was performed to observe the outcome of symptoms and the recurrence after operation. All the 44 patients successfully completed the operation and were divided into the OA group (21 cases) and the LA group (11 cases of transabdominal laparoscopic adrenalectomy [TLA] and 12 cases of retroperitoneal laparoscopic adrenalectomy [RLA]) according to different operation methods. The analysis results showed that the proportion of estimated blood loss (EBL) >100 mL and the postoperative length of stay (PLOS) in the LA group were superior to those in the OA group, and there were no significant differences in other surgical indicators ( > .05); subgroup analysis was conducted for patients in the LA group according to different surgical pathways, and the results showed that there were no significant differences in each surgical indicator between TLA and RLA ( > .05). Among the 44 patients, 15 (34.1%) had intraoperative complications, 19 (43.2%) had postoperative complications, and 5 (21.7%) were converted from LA to OA. The median follow-up time was 68 (5-162) months. For adrenal tumors with diameter ≥10 cm, both LA and OA have relatively large damage to the patients, and the incidence of conversion to open surgery is also high. However, LA is superior to OA in EBL and PLOS. Given the fact that giant adrenal tumors are mainly pheochromocytoma and paraganglioma and have an increased possibility of malignancy, we suggest that the relationship between tumors and peripheral important blood vessels and organs should be carefully evaluated before operation, and the operative methods should be selected according to the experience of the surgeon.
本研究的目的是通过总结巨大肾上腺肿瘤的临床特征及治疗经验,比较开放性肾上腺切除术(OA)和腹腔镜肾上腺切除术(LA)的疗效及安全性。回顾性分析了2006年1月至2022年8月期间兰州大学第二医院收治的44例肾上腺肿瘤直径≥10 cm患者的临床资料。肿瘤平均直径为11.6±1.8 cm。进行定期随访以观察症状结局及术后复发情况。44例患者均成功完成手术,并根据不同手术方式分为OA组(21例)和LA组(经腹腹腔镜肾上腺切除术[TLA]11例及腹膜后腹腔镜肾上腺切除术[RLA]12例)。分析结果显示,LA组估计失血量(EBL)>100 mL的比例及术后住院时间(PLOS)均优于OA组,其他手术指标差异无统计学意义(>0.05);根据不同手术入路对LA组患者进行亚组分析,结果显示TLA与RLA各项手术指标差异无统计学意义(>0.05)。44例患者中,15例(34.1%)发生术中并发症,19例(43.2%)发生术后并发症,5例(21.7%)由LA转为OA。中位随访时间为68(5~162)个月。对于直径≥10 cm的肾上腺肿瘤,LA和OA对患者的损伤均较大,转为开放手术的发生率也较高。然而,LA在EBL和PLOS方面优于OA。鉴于巨大肾上腺肿瘤主要为嗜铬细胞瘤和副神经节瘤且恶性可能性增加,我们建议术前应仔细评估肿瘤与周围重要血管及器官的关系,并根据术者经验选择手术方式。